TheStreet's Jim Cramer says he doesn't like GoDaddy because he doesn't know what's going to get this stock going higher.
Schlumberger’s scale, market leadership and pricing power make it defensible amidst low oil prices.
TheStreet's Jim Cramer says we're seeing a top in biotechs.
TheStreet's Jim Cramer says he's keeping an eye on Monsanto Wednesday to see if the company can turn the tide when it reports Q2 results before the open.
Healthcare, biotech, the U.S. dollar and oil prices are what investors will want to watch in Q2, says TheStreet's Jim Cramer.
Jim Cramer says he's keeping an eye on Freshpet Tuesday as the natural and organic pet food maker reports fourth quarter results after the close.
Jim Cramer answers your Twitter questions from the NYSE floor and says UPS has lost its edge, and he likes FedEx.
Micron Technology and Monsanto report earnings next week but Jim Cramer says he doesn't love either and would sell into any strength.
Dow Chemical announced on Friday it will split off its chlorine business in a $5 billion deal. TheStreet's Jim Cramer says this is an amazing opportunity to buy the stock.
TheStreet's Jim Cramer says he's concerned that Finish Line will once again will disappoint when it releases fourth quarter earnings results Friday before the open.